Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-11-15

Clinical Trial Update: Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating toremifene citrate to prevent bone fractures in men with prostate cancer on androgen deprivation therapy has completed; the update no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Toremifene citrate (toremifene citrate)

Snippet

Sponsor: GTx | Conditions: Prostate Cancer, Osteoporosis | Phase 3 | Status: COMPLETED